Imaging the Tumor Microenvironment.

Area of Science:

• Oncology
• Medical Imaging
• Cancer Biology

Background:

• The tumor microenvironment (TME) comprises tumor cells, stromal cells, immune cells, and the extracellular milieu.
• Alterations in the TME significantly influence cancer progression, metastasis, and treatment outcomes.
• Non-invasive imaging of the TME provides critical data on cancer aggressiveness, metastatic potential, and early treatment response.

Purpose of the Study:

• To provide an overview of non-invasive in vivo imaging techniques for the tumor microenvironment.
• To discuss current clinical and research imaging modalities and their applications in cancer.
• To highlight the potential of novel imaging strategies for monitoring TME changes and evaluating cancer therapies.

Main Methods:

• Review of current non-invasive imaging modalities including Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Magnetic Resonance Imaging (MRI), and Near-Infrared (NIR) fluorescence imaging.
• Discussion of imaging agents and strategies targeting specific TME components and physiological parameters.
• Examination of applications in both human patients and preclinical mouse models.

Main Results:

• PET, MRI, and optical imaging can visualize key TME aspects such as tumor-associated inflammation (macrophages, T cells), hypoxia, altered pH, and specific enzymes and integrins.
• These imaging modalities offer insights into the complex cellular and physiological landscape of tumors.
• Existing imaging agents and strategies are available for clinical use, with ongoing research into novel approaches.

Conclusions:

• Non-invasive imaging is crucial for understanding the tumor microenvironment's role in cancer.
• Current imaging technologies enable the assessment of various TME characteristics in vivo.
• Continued research into novel imaging agents and strategies holds promise for improved cancer monitoring and therapeutic development.